魯信創投(600783.SH):子公司擬3.2億元參投成都魯信基金 主投電子信息技術等
格隆匯 2 月 4日丨魯信創投(600783.SH)公佈,為深化公司在川渝地區的佈局,抓住高端裝備製造、電子信息技術和生物醫藥等戰略新興產業的發展機遇,公司全資子公司高新投擬聯合四川省國有資產經營投資管理有限責任公司、成都市菁蓉創富投資有限公司、青島福瑞馳投資管理有限公司共同參與投資成都魯信基金,其中高新投作為LP認繳出資金額3.2億元,佔成都魯信基金出資比例42.67%。
成都魯信基金擬重點投資於成都及周邊地區,面向全國,主要投資方向為電子信息技術、高端裝備製造業、新材料及生物醫藥行業。
成都魯信基金的設立有助於不斷深化公司在川渝地區的佈局,抓住高端裝備製造、電子信息技術和生物醫藥等戰略新興產業的發展機遇,發掘優質項目,分散投資風險,優化投資結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.